Skip to main content

Table 10 C-Reactive Protein levels: effectiveness of treatments

From: The use of LeptiCore® in reducing fat gain and managing weight loss in patients with metabolic syndrome

 

CRP (mean mg/l)

change (%)

 

Initial

8 Weeks

8 Weeks - Initial

Formula B (↑dose)

11.58 ± 1.11

8.17 ± 0.61b*

-29.45

Formula A (↓dose)

10.99 ± 1.26

9.33 ± 0.43a

-15.10

Placebo

12.46 ± 1.30

12.05 ± 1.39

-3.31

  1. ap < 0.05; bp < 0.001 compared with Placebo
  2. *p < 0.05; **p < 0.001 compared with Formula A
  3. p < 0.05; p < 0.001 compared with Initial; intragroup analysis